Moldovan Rareş-Petru, Deuther-Conrad Winnie, Horti Andrew G, Brust Peter
Helmholtz-Zentrum Dresden-Rossendorf e.V., Institute of Radiopharmaceutical Cancer Research, Permoserstr. 15, 04318 Leipzig, Germany.
Johns Hopkins School of Medicine, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Baltimore, MD 21287, USA.
Molecules. 2017 Jan 4;22(1):77. doi: 10.3390/molecules22010077.
A small series of indol-3-yl-oxoacetamides was synthesized starting from the literature known -(adamantan-1-yl)-2-(5-(furan-2-yl)-1-pentyl-1-indol-3-yl)-2-oxoacetamide () by substituting the 1-pentyl-1-indole subunit. Our preliminary biological evaluation showed that the fluorinated derivative 8 is a potent and selective CB₂ ligand with = 6.2 nM.
从文献中已知的-(金刚烷-1-基)-2-(5-(呋喃-2-基)-1-戊基-1-吲哚-3-基)-2-氧代乙酰胺()开始,通过取代1-戊基-1-吲哚亚基,合成了一小系列吲哚-3-基-氧代乙酰胺。我们的初步生物学评估表明,氟化衍生物8是一种有效的选择性CB₂配体,IC₅₀ = 6.2 nM。